| Lung Cancer |
1 |
1 |
| Chemotherapy |
0 |
0.99 |
| Biologic Therapy |
0 |
0.46 |
| Non-Small Cell Lung Cancer |
0 |
0.98 |
| Brachial |
0 |
0.31 |
| Immunotherapy |
0 |
0.24 |
| Small Cell Lung Cancer |
0 |
0.24 |
| Cancer |
0 |
0.19 |
| Toxicology |
0 |
0.19 |
| Hepatocellular Carcinoma |
0 |
0.18 |
| Lung |
0 |
0.17 |
| Metastasis |
0 |
0.16 |
| Platinum |
0 |
0.12 |
| Histology |
0 |
0.1 |
| HIV Infection |
0 |
0.09 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.08 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| Biomarker |
0 |
0.05 |
| Dermatitis |
0 |
0.03 |
| Health Care Reform |
0 |
0.03 |
| Tobacco Cessation |
0 |
0.03 |
| Central Nervous System |
0 |
0.02 |
| Child |
0 |
0.02 |
| Europe |
0 |
0.02 |
| Imbalance |
0 |
0.02 |
| Liver |
0 |
0.02 |
| Outpatient Clinic |
0 |
0.02 |
| Smoking |
0 |
0.02 |
| Social Media |
0 |
0.02 |
| Tennessee |
0 |
0.02 |